NCT06356922View on ClinicalTrials.gov

Study Assessing RLT Using [177Lu]Lu-PentixaTher for Relapsed/Refractory CXCR4+ Acute Leukemia.

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

October 22, 2024

Primary Completion Date

October 22, 2027

Study Completion Date

October 22, 2027

Conditions
Acute Leukemia
Interventions
DRUG

Experimental drug [177Lu]Lu-PentixaTher

Injection of \[177Lu\]Lu-PentixaTher

Trial Locations (4)

33604

RECRUITING

CHU de Bordeaux, Bordeaux

44000

RECRUITING

CHU de Nantes, Nantes

49100

RECRUITING

CHU d'Angers, Angers

63000

RECRUITING

CHU de Clermont-Ferrand, Clermont-Ferrand

All Listed Sponsors
lead

Nantes University Hospital

OTHER